• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
TRAIL-expressing CD8+ T cells mediate tolerance following soluble peptide-induced peripheral T cell deletion.表达 TRAIL 的 CD8+ T 细胞介导可溶性肽诱导的外周 T 细胞耗竭后的耐受。
J Leukoc Biol. 2010 Dec;88(6):1217-25. doi: 10.1189/jlb.0610343. Epub 2010 Aug 31.
2
Injection of soluble antigen into the anterior chamber of the eye induces expansion and functional unresponsiveness of antigen-specific CD8+ T cells.将可溶性抗原注射到眼前房可诱导抗原特异性CD8 + T细胞扩增并使其功能无反应性。
J Immunol. 2002 Nov 15;169(10):5630-7. doi: 10.4049/jimmunol.169.10.5630.
3
Systemic immunological tolerance to ocular antigens is mediated by TRAIL-expressing CD8+ T cells.靶向 TRAIL 的 CD8+T 细胞介导眼组织抗原的系统性免疫耐受。
J Immunol. 2011 Jan 15;186(2):791-8. doi: 10.4049/jimmunol.1002678. Epub 2010 Dec 17.
4
Maternal CD4⁺ and CD8⁺ T cell tolerance towards a fetal minor histocompatibility antigen in T cell receptor transgenic mice.母体 CD4+ 和 CD8+ T 细胞对 T 细胞受体转基因小鼠中胎儿次要组织相容性抗原的耐受。
Biol Reprod. 2013 Oct 31;89(4):102. doi: 10.1095/biolreprod.113.110445. Print 2013 Oct.
5
Immunological tolerance to muscle autoantigens involves peripheral deletion of autoreactive CD8+ T cells.针对肌肉自身抗原的免疫耐受涉及外周血中自身反应性 CD8+T 细胞的删除。
PLoS One. 2012;7(5):e36444. doi: 10.1371/journal.pone.0036444. Epub 2012 May 3.
6
Urinary bladder epithelium antigen induces CD8+ T cell tolerance, activation, and autoimmune response.膀胱上皮抗原诱导CD8 + T细胞耐受、激活及自身免疫反应。
J Immunol. 2007 Jan 1;178(1):539-46. doi: 10.4049/jimmunol.178.1.539.
7
Intestinal epithelial antigen induces mucosal CD8 T cell tolerance, activation, and inflammatory response.肠道上皮抗原诱导黏膜CD8 T细胞耐受、激活及炎症反应。
J Immunol. 2004 Oct 1;173(7):4324-30. doi: 10.4049/jimmunol.173.7.4324.
8
Functional tolerance of CD8+ T cells induced by muscle-specific antigen expression.肌肉特异性抗原表达诱导的CD8 + T细胞功能耐受
J Immunol. 2008 Jul 1;181(1):408-17. doi: 10.4049/jimmunol.181.1.408.
9
Peripheral deletion of antigen-specific T cells leads to long-term tolerance mediated by CD8+ cytotoxic cells.抗原特异性T细胞的外周缺失导致由CD8 + 细胞毒性细胞介导的长期耐受。
J Immunol. 2005 Apr 1;174(7):4098-104. doi: 10.4049/jimmunol.174.7.4098.
10
PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues.程序性死亡受体1(PD-1)调节淋巴结和组织中自身反应性CD8 + T细胞对抗原的反应。
J Immunol. 2007 Oct 15;179(8):5064-70. doi: 10.4049/jimmunol.179.8.5064.

引用本文的文献

1
The Emerging Jamboree of Transformative Therapies for Autoimmune Diseases.新兴的自身免疫性疾病变革性疗法大爆发。
Front Immunol. 2020 Mar 31;11:472. doi: 10.3389/fimmu.2020.00472. eCollection 2020.
2
The Role of TRAIL/DRs in the Modulation of Immune Cells and Responses.肿瘤坏死因子相关凋亡诱导配体/死亡受体在免疫细胞及免疫反应调节中的作用
Cancers (Basel). 2019 Sep 30;11(10):1469. doi: 10.3390/cancers11101469.
3
Interactions of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) with the Immune System: Implications for Inflammation and Cancer.肿瘤坏死因子相关凋亡诱导配体(TRAIL)与免疫系统的相互作用:对炎症和癌症的影响
Cancers (Basel). 2019 Aug 13;11(8):1161. doi: 10.3390/cancers11081161.
4
Therapeutic applications of TRAIL receptor agonists in cancer and beyond.TRAIL受体激动剂在癌症及其他领域的治疗应用。
Pharmacol Ther. 2015 Nov;155:117-31. doi: 10.1016/j.pharmthera.2015.09.001. Epub 2015 Sep 5.
5
Impact of sepsis on CD4 T cell immunity.脓毒症对CD4 T细胞免疫的影响。
J Leukoc Biol. 2014 Nov;96(5):767-77. doi: 10.1189/jlb.5MR0114-067R. Epub 2014 May 2.
6
Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer.病毒载体 TRAIL 基因治疗癌症的研究进展。
Cancers (Basel). 2011 Feb 10;3(1):603-20. doi: 10.3390/cancers3010603.
7
T-cell-mediated immunity and the role of TRAIL in sepsis-induced immunosuppression.T细胞介导的免疫以及TRAIL在脓毒症诱导的免疫抑制中的作用。
Crit Rev Immunol. 2013;33(1):23-40. doi: 10.1615/critrevimmunol.2013006721.
8
Cell death in the maintenance and abrogation of tolerance: the five Ws of dying cells.细胞死亡在耐受的维持和终止中的作用:濒死细胞的五个 W。
Immunity. 2011 Oct 28;35(4):456-66. doi: 10.1016/j.immuni.2011.08.011.
9
Immune unresponsiveness to secondary heterologous bacterial infection after sepsis induction is TRAIL dependent.脓毒症诱导后对二次异源细菌感染的免疫无反应性依赖于 TRAIL。
J Immunol. 2011 Sep 1;187(5):2148-54. doi: 10.4049/jimmunol.1101180. Epub 2011 Jul 25.
10
Armed response: how dying cells influence T-cell functions.武装应答:濒死细胞如何影响 T 细胞功能。
Immunol Rev. 2011 May;241(1):77-88. doi: 10.1111/j.1600-065X.2011.01006.x.

本文引用的文献

1
Sepsis-induced apoptosis leads to active suppression of delayed-type hypersensitivity by CD8+ regulatory T cells through a TRAIL-dependent mechanism.脓毒症诱导的细胞凋亡通过 TRAIL 依赖的机制导致 CD8+调节性 T 细胞对迟发型超敏反应的主动抑制。
J Immunol. 2010 Jun 15;184(12):6766-72. doi: 10.4049/jimmunol.0904054. Epub 2010 May 12.
2
Mechanisms maintaining peripheral tolerance.维持外周耐受的机制。
Nat Immunol. 2010 Jan;11(1):21-7. doi: 10.1038/ni.1817. Epub 2009 Dec 17.
3
Regulatory T cells exert checks and balances on self tolerance and autoimmunity.调节性 T 细胞对自身耐受和自身免疫起着制衡作用。
Nat Immunol. 2010 Jan;11(1):7-13. doi: 10.1038/ni.1818. Epub 2009 Dec 17.
4
Activation-induced CD154 expression abrogates tolerance induced by apoptotic cells.激活诱导的CD154表达可消除凋亡细胞诱导的耐受性。
J Immunol. 2009 Nov 15;183(10):6114-23. doi: 10.4049/jimmunol.0901676. Epub 2009 Oct 19.
5
Immunogenic and tolerogenic cell death.免疫原性和耐受性细胞死亡
Nat Rev Immunol. 2009 May;9(5):353-63. doi: 10.1038/nri2545.
6
Intestinal tolerance is converted to autoimmune enteritis upon PD-1 ligand blockade.在阻断PD-1配体后,肠道耐受性转变为自身免疫性肠炎。
J Immunol. 2009 Feb 15;182(4):2102-12. doi: 10.4049/jimmunol.0802769.
7
Immunogenic cell death modalities and their impact on cancer treatment.免疫原性细胞死亡方式及其对癌症治疗的影响。
Apoptosis. 2009 Apr;14(4):364-75. doi: 10.1007/s10495-008-0303-9.
8
In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure.高剂量变应原暴露下体内向分泌白细胞介素-10的调节性T细胞转变
J Exp Med. 2008 Nov 24;205(12):2887-98. doi: 10.1084/jem.20080193. Epub 2008 Nov 10.
9
CD8 T cells utilize TRAIL to control influenza virus infection.CD8 T细胞利用肿瘤坏死因子相关凋亡诱导配体(TRAIL)来控制流感病毒感染。
J Immunol. 2008 Oct 1;181(7):4918-25. doi: 10.4049/jimmunol.181.7.4918.
10
The TRAIL of helpless CD8+ T cells in HIV infection.HIV感染中无助CD8 + T细胞的肿瘤坏死因子相关凋亡诱导配体
AIDS Res Hum Retroviruses. 2008 Sep;24(9):1175-83. doi: 10.1089/aid.2008.0062.

表达 TRAIL 的 CD8+ T 细胞介导可溶性肽诱导的外周 T 细胞耗竭后的耐受。

TRAIL-expressing CD8+ T cells mediate tolerance following soluble peptide-induced peripheral T cell deletion.

机构信息

Department of Urology, University of Iowa, Iowa City, Iowa 52242-1089, USA.

出版信息

J Leukoc Biol. 2010 Dec;88(6):1217-25. doi: 10.1189/jlb.0610343. Epub 2010 Aug 31.

DOI:10.1189/jlb.0610343
PMID:20807702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2996898/
Abstract

Peripheral tolerance controls the action of self-reactive T cells that escape thymic deletion. We showed previously that deletion of Ag-specific CD4+ T cells induced a CD8+ T(reg) population that maintained tolerance by deleting T cells with the same Ag specificity. The present study explored the mechanism of action of these CD8+ T(reg). Following OT-II T cell deletion by soluble OVA₃₂₃₋₃₃₉, B6 mice were unresponsive to challenge after CFA/OVA immunization, and Trail⁻/⁻ or Dr5⁻/⁻ mice were immune, although all strains displayed similar OT-II peripheral deletion. Interestingly, B6 mice remained tolerant to OVA even after a second infusion of OT-II T cells. Tolerance could be transferred to naïve recipients using CD8+ T cells from B6 or Dr5⁻/⁻ mice that experienced peptide-induced peripheral OT-II deletion but not from Trail⁻/⁻ mice. Subsequent investigation found that the mechanism of action of the CD8+ T(reg) was TRAIL-mediated OT-II T cell deletion in a TCR-specific manner. Furthermore, the tolerance was transient, as it was established by 14 days after peptide injection but lost by Day 56. Together, these data provide evidence to suggest that the mechanism behind transient peripheral tolerance induced following T cell deletion is the cytotoxic activity of TRAIL-expressing CD8+ T(reg).

摘要

外周耐受控制着逃避胸腺删除的自身反应性 T 细胞的作用。我们之前曾表明,特异性 Ag 的 CD4+T 细胞的删除诱导了 CD8+T(reg)群体,该群体通过删除具有相同 Ag 特异性的 T 细胞来维持耐受。本研究探讨了这些 CD8+T(reg)的作用机制。在可溶性 OVA₃₂₃₋₃₃₉诱导 OT-II T 细胞删除后,B6 小鼠在 CFA/OVA 免疫后对挑战无反应,而 Trail⁻/⁻或 Dr5⁻/⁻小鼠具有免疫性,尽管所有品系均显示出相似的 OT-II 外周删除。有趣的是,即使在第二次输注 OT-II T 细胞后,B6 小鼠仍对 OVA 保持耐受。使用经历肽诱导外周 OT-II 删除的 B6 或 Dr5⁻/⁻小鼠的 CD8+T 细胞,但不能使用 Trail⁻/⁻小鼠的 CD8+T 细胞,可以将耐受转移到幼稚受体。随后的研究发现,CD8+T(reg)的作用机制是以 TCR 特异性方式通过 TRAIL 介导的 OT-II T 细胞删除。此外,这种耐受是短暂的,因为它在肽注射后 14 天建立,但在第 56 天失去。综上所述,这些数据提供了证据表明,T 细胞删除后诱导的短暂外周耐受的背后机制是表达 TRAIL 的 CD8+T(reg)的细胞毒性活性。